SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-019610
Filing Date
2024-05-01
Accepted
2024-05-01 16:12:31
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20240331.htm   iXBRL 10-Q 733828
2 EX-10.1 cort33124ex101ninthamendme.htm EX-10.1 22499
3 EX-10.2 cort33124ex102optime.htm EX-10.2 309979
4 EX-10.3 cort33124ex103zuorasublease.htm EX-10.3 987286
5 EX-31.1 cort33124ex311.htm EX-31.1 9671
6 EX-31.2 cort33124ex312.htm EX-31.2 9630
7 EX-32.1 cort33124ex321.htm EX-32.1 5329
8 EX-32.2 cort33124ex322.htm EX-32.2 5255
14 image_01.jpg GRAPHIC 218889
15 image_0a.jpg GRAPHIC 244150
16 image_1a.jpg GRAPHIC 240375
17 image_1b.jpg GRAPHIC 631
18 image_2a.jpg GRAPHIC 279886
19 image_2b.jpg GRAPHIC 631
20 image_3.jpg GRAPHIC 247581
21 image_4.jpg GRAPHIC 174723
22 image_5.jpg GRAPHIC 178693
23 image_6.jpg GRAPHIC 1324677
24 image_7.jpg GRAPHIC 328188
25 image_8.jpg GRAPHIC 437764
  Complete submission text file 0001628280-24-019610.txt   10536632

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20240331.xsd EX-101.SCH 33429
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20240331_cal.xml EX-101.CAL 65267
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20240331_def.xml EX-101.DEF 105752
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20240331_lab.xml EX-101.LAB 367899
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20240331_pre.xml EX-101.PRE 240858
76 EXTRACTED XBRL INSTANCE DOCUMENT cort-20240331_htm.xml XML 389412
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 24903140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)